Evaluate the Efficacy and Safety of LO2A Eye Drops for Symptomatic Improvement of Dry Eye in Patients With Sjögren's Syndrome
NCT03319420
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Due to Sjögren's Syndrome
Interventions
DRUG:
LO2A eye drops
DRUG:
Systane Ultra UD
Sponsor
Ocuwize LTD